Category: SiemensSyndicate content

Exec at MDT explains how COV gained $43B payout | The week in medtech M&A

September 24, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together; Medtronic and Covidien prepare 1st Integration Summit; FTC approves Cerner's $1.3B Siemens health IT buy; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

September 17, 2014 by Brian Johnson

FTC approves Cerner's $1.3B Siemens health IT buy

September 19, 2014 by Arezu Sarvestani

Cerner gets federal approval for its $1.3 billion acquisition of Siemens' health information technology business.

FTC approves Cerner's $1.3B Siemens health IT buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta

Siemens sells clinical microbiology biz to Beckman Coulter

July 17, 2014 by Arezu Sarvestani

Beckman Coulter picks up Siemens Healthcare Diagnostics' clinical microbiology business in a closed-doors deal.

Siemens sells clinical microbiology biz to Beckman Coulter

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Siemens Healthcare spinout chatter ramps up | MassDevice.com On Call

July 10, 2014 by Brad Perriello

Siemens is reportedly investigating a spinout of its Siemens Healthcare division's IT unit, which could be worth more than $1 billion.

MassDevice.com On Call

Chatter about a possible spinout for Siemens Healthcare (NYSE:SI) ramped up yesterday on a report from "2 people familiar with the plans" who said the German conglomerate is actively investigating a possible sale of its hospital database and IT business.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Press Release: Siemens files PMA for digital breast tomosynthesis

June 27, 2014 by Arezu Sarvestani

Press Release: Siemens files PMA for digital breast tomosynthesis

MALVERN, Pa. -- Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration® with Breast Tomosynthesis option.

Siemens seeks FDA approval for next-gen mammograms with tomosynthesis

June 27, 2014 by Arezu Sarvestani

Siemens files a premarket approval application to add 3D breast imaging to its Mammomat Inspiration digital mammograms.

Siemens seeks FDA approval for 3D mammograms

Healthcare giant Siemens (NYSE:SI) this week filed its premarket approval application to get the FDA's OK to add a tomosynthesis option to its Mammomat Inspiration mammography system.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp